Medtech and COVID-19: 6 months into the public health emergency

When U.S. regulators first declared COVID-19 a public health emergency — which took effect exactly six […]

When U.S. regulators first declared COVID-19 a public health emergency — which took effect exactly six months ago — the infectious disease was deemed a low risk to the American public. Today, the known U.S. case count tops 4.3 million.
The medtech industry now has close to half a year under its belt of producing millions of diagnostic tests in addition to respiratory support devices and other equipment to help healthcare workers respond to the coronavirus. The need hasn’t slowed, but unlike in March and April, much demand has also returned to many companies’ traditional product lines, including for implants used in elective surgeries.
While the interest in products new and old bodes well for the sector’s recovery as other industries face starker struggles, unique regulatory, supply chain and sales challenges remain.
MedTech Dive examines some of those challenges in the stories below.

Medtechs reboot with patients, providers after elective surgeries bottom out

By Maria Rachal • July 27, 2020

Recovery of procedures critical to device companies came quicker than many in the industry expected. Now, device companies are adapting as business volumes normalize and COVID-19 continues to spread. Read the full article 

Coronavirus testing hits a wall: Where do we go from here?

By Greg Slabodkin • July 27, 2020

As LabCorp and Quest are backlogged in delivering molecular test results, some public health officials are calling for a shift in testing approach from slow and accurate to fast and good enough to meet demand. Read the full article 

Diagnostics makers must plan for EUA products to have post-pandemic future

By Greg Slabodkin • July 27, 2020

An extension to the public health emergency formalized a reprieve for emergency use authorizations, but manufacturers should act now if they want products to stay on the market when the crisis ends, compliance experts say. Read the full article 

How COVID-19 is challenging and changing medtech supply chain management

By Maria Rachal • July 27, 2020

Four experts share insights on the supply and demand hangups medtechs have been working through during the pandemic, and a few early takeaways the industry can carry forward. Read the full article 

Original Article: (https://www.medtechdive.com/news/coronavirus-medtech-6-months-public-health-emergency/582235/)